SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1369Nov 29, 2005 /PRNewswire via COMTEX News Network/ -- HAMILTON, Bermuda and EJohn McCarthy-11/29/2005
1368Press Release Source: Forest Laboratories Holdings, Ltd. Gedeon Richter and FoJohn McCarthy-11/29/2005
1367Celtic Pharma Completes Acquisition of Exclusive Worldwide Rights to XERECEPT FrJohn McCarthy-11/29/2005
1366Neurobiological Technologies, Inc. Announces Initiation of Viprinex(TM) (Ancrod)John McCarthy-11/22/2005
1365Dutton Report 11/8/2005 jmdutton.comJohn McCarthy-11/18/2005
1364Additional notes I forgot to add: Current Viprinex Clinical Sites: clinicaltriaJohn McCarthy-11/12/2005
1363Notes from the current SCIMITAR report: TimeLine (from SCIMITAR) Note: Fiscal John McCarthy-11/12/2005
1362What follows may contain inaccuracies so please correct as you find them .... IJohn McCarthy-11/9/2005
1361Got it. Let me know if any other Q's come to mind between now and Dec. 6th.JMarcus-11/8/2005
1360Hi Marc ... my question would be simple ... of the 50 or so planned stroke sitJohn McCarthy-11/8/2005
1359This year's stockholders' meeting is scheduled for Dec. 6th. There'JMarcus-11/8/2005
1358mopgcw - Thank you very much for catching me up. And (unfortunately) I think yJohn McCarthy-11/5/2005
1357Hope you are feeling better and welcome back. Proxy statements released last mopgcw-11/4/2005
1356mopgcw I've been sick for a little while and just got home early this weekJohn McCarthy-11/4/2005
1355I was sorely disappointed in the proxy proposal to divide the board into 3-classmopgcw-11/4/2005
1354retraction / clarification a more precise statement about the start up of the John McCarthy-9/22/2005
1353Viprinex PH III should start by next week at 50 centers. from billyomayn on YahJohn McCarthy-9/21/2005
1352The founder of Celtic is the old Sugen CEO, Evans-Freke, so they have some crediBiomaven-9/20/2005
1351Scimitar Equity Research Issues Mid-Quarter Update of Neurobiological Technologisim1-9/20/2005
1350Paul Freiman addresses investors tomorrow: Event: The Second Annual Merriman CuJMarcus-9/20/2005
1349Check out the Celtic Pharma website: celticpharma.com It is a "virtual coJMarcus-9/20/2005
1348Neurobiological Technologies, Inc. Announces Sale of XERECEPT(R) to Celtic Pharmsim1-9/20/2005
1347Neurobiological Technologies, Inc. Announces Initiation of XERECEPT(R) Extended mopgcw-8/25/2005
1346Scimitar Equity Research Issues Review of Neurobiological Technologies, Inc. Thusim1-8/25/2005
1345Neurobiological Technologies Reports Fourth Quarter and Fiscal 2005 Financial Remopgcw-8/24/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News